Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis

This study has been completed.
Roche Pharma AG
Information provided by:
Cambridge University Hospitals NHS Foundation Trust Identifier:
First received: February 16, 2006
Last updated: NA
Last verified: October 2005
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: May 2005
  Estimated Primary Completion Date: No date given